Pion. Agro Extr. (519439)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at ₹10.25, a roughly 16% discount to stated book value of ₹12.17, offering a potential asset-based margin of safety.
• Positive ROCE of 1.72% suggests some capital productivity exists despite the negative ROE.
• Tiny market cap of ₹11 Cr means even modest asset monetization could have an outsized impact on per-share value.

Concerns

• Latest quarter shows sales of ₹0 Cr and a net loss of ₹1 Cr; the underlying business appears non-operating and cash-burning.
• Negative ROE of -11.29% and profit growth of -1550% signal ongoing value destruction.
• Piotroski F-score of 3/9 indicates weak financial health across profitability, efficiency, and balance-sheet quality.
• Absence of promoter holding and dividend data raises transparency and shareholder-return concerns.

AI Analysis

Let me start with what I know. Pion Agro Extr. sells at ₹10.25 per share while its book value is ₹12.17. That gives a price-to-book of 0.84, so the market is offering me a rupee of assets for 84 paise. In Graham's language, a discount to book can create a margin of safety. But that is only the starting point, not a conclusion. This is a business with no reported sales in the latest quarter and a net loss of ₹1 Cr. Over the period, profit growth collapsed by 1550%, and return on equity is negative at -11.29%. A company that consistently loses money erodes the very book value I am supposedly buying. The P/E is meaningless at 0.00 because there are no earnings to value. The Piotroski F-score of 3 out of 9 reinforces the picture: deteriorating financial health, poor profitability, and weak fundamentals. ROCE of 1.72% is far below what I would demand from a competitive edible oil business; it barely covers the cost of capital, and with zero sales, the operating engine appears to have stopped. I also receive no dividend while waiting. There is no promoter holding data disclosed, which makes me uneasy about corporate governance and aligned incentives. The 52-week range of ₹19.68 to ₹27.64 shows the stock has fallen sharply, and markets are usually right to discount deteriorating assets. I cannot call this a growing enterprise or a quality compounder. For it to work as an investment, the asset value must be real, recoverable, and preferably monetized. I would need to examine the balance sheet in detail, understand every liability, and see evidence of either an operating restart or a liquidation plan. Until then, this is a speculative asset play, not a business I can confidently own. Price is low; value is uncertain. That is not enough.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer